Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The purinergic P2Y12 receptor (P2Y12) is a G protein-coupled receptor that primarily functions as a chemoreceptor for adenosine diphosphate (ADP). It plays a crucial role in platelet aggregation and microglial function in the central nervous system. Targeting P2Y12 with antagonists like clopidogrel is a common strategy to prevent thromboembolic events.
Irreversible antagonist of P2Y12 receptor, inhibiting ADP-induced platelet aggregation
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Purinergic P2Y12 receptor (P2Y12).